Miacalcin Injection

  • Bone disorders

Miacalcin Injection Generic Name & Formulations

General Description

Calcitonin-salmon 200 IU/mL; soln for SC or IM inj.

Pharmacological Class


How Supplied

Multi-dose vials (2mL)—1


Miacalcin Injection Indications


Paget's disease of bone. Hypercalcemia. Postmenopausal osteoporosis in women >5yrs postmenopausal.

Miacalcin Injection Dosage and Administration


Give by IM inj across multiple sites if total dose >2mL. Paget's: 100 IU SC or IM daily. Hypercalcemia: initially 4 IU/kg SC or IM every 12hrs, may increase after 1–2 days to 8 IU/kg every 12hrs, and then after 2 more days to max 8 IU/kg every 6hrs. Postmenopausal osteoporosis: 100 IU SC or IM daily.


Not established.

Miacalcin Injection Contraindications

Not Applicable

Miacalcin Injection Boxed Warnings

Not Applicable

Miacalcin Injection Warnings/Precautions


Correct hypocalcemia and other mineral metabolism disorders before initiating; monitor serum calcium and hypocalcemia symptoms during therapy. Increased risk of malignancies. Consider periodic exams of urine sediment; serum alkaline phosphatase and urinary hydroxyproline in Paget's. Postmenopausal osteoporosis: supplement diet with calcium 1g/day and Vit.D 400 IU/day. Re-evaluate periodically. Pregnancy. Nursing mothers.

Miacalcin Injection Pharmacokinetics

See Literature

Miacalcin Injection Interactions


May antagonize lithium (consider lithium dose adjustment).

Miacalcin Injection Adverse Reactions

Adverse Reactions

Nausea, vomiting, local inflammation, flushing, rash; hypersensitivity reactions, anaphylaxis, hypocalcemia, antibody formation.

Miacalcin Injection Clinical Trials

See Literature

Miacalcin Injection Note

Not Applicable

Miacalcin Injection Patient Counseling

See Literature